Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug

被引:59
|
作者
Carlyle, Wenda C. [1 ]
McClain, James B. [1 ]
Tzafriri, Abraham R. [2 ,3 ]
Bailey, Lynn [2 ]
Zani, Brett G. [2 ]
Markham, Peter M. [2 ]
Stanley, James R. L. [2 ]
Edelman, Elazer R. [3 ]
机构
[1] Micell Technol Inc, Durham, NC 27713 USA
[2] CBSET Inc, Concord Biomed Sci & Emerging Technol, Lexington, MA 02421 USA
[3] MIT, Cambridge, MA 02139 USA
关键词
Stent; PLGA; Crystalline; Sirolimus; Modeling; Pharmacokinetic; ELUTING STENT; RELEASE; DEPOSITION; SIROLIMUS; ARTERIAL;
D O I
10.1016/j.jconrel.2012.07.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Current drug eluting stent (DES) technology is not optimized with regard to the pharmacokinetics of drug delivery. A novel, absorbable-coating sirolimus-eluting stent (AC-SES) was evaluated for its capacity to deliver drug more evenly within the intimal area rather than concentrating drug around the stent struts and for its ability to match coating erosion with drug release. The coating consisted of absorbable poly-lactide-co-glycolic acid (PLGA) and crystalline sirolimus deposited by a dry-powder electrostatic process. The AC-SES demonstrated enhanced drug stability under simulated use conditions and consistent drug delivery balanced with coating erosion in a porcine coronary implant model. The initial drug burst was eliminated and drug release was sustained after implantation. The coating was absorbed within 90 days. Following implantation into porcine coronary arteries the AC-SES coating is distributed in the surrounding intimal tissue over the course of several weeks. Computational modeling of drug delivery characteristics demonstrates how distributed coating optimizes the load of drug immediately around each stent strut and extends drug delivery between stent struts. The result was a highly efficient arterial uptake of drug with superior performance to a clinical bare metal stent (BMS). Neointimal thickness (0.17+/-0.07 mm vs. 0.28+/-0.11 mm) and area percent stenosis (22+/-9% vs. 35+/-12%) were significantly reduced (p<0.05) by the AC-SES compared to the BMS 30 days after stent implantation in an overlap configuration in porcine coronary arteries. Inflammation was significantly reduced in the AC-SES compared to the BMS at both 30 and 90 days after implantation. Biocompatible, rapidly absorbable stent coatings enable the matching of drug release with coating erosion and provide for the controlled migration of coating material into tissue to reduce vicissitudes in drug tissue levels, optimizing efficacy and reducing potential toxicity. (C) 2012 Elsevier B. V. All rights reserved.
引用
收藏
页码:561 / 567
页数:7
相关论文
共 50 条
  • [11] Stents as a platform for drug delivery
    Lei, Lei
    Guo, Sheng-Rong
    Chen, Wei-Luan
    Rong, Hao-Jun
    Lu, Fei
    EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (06) : 813 - 831
  • [12] Optimization of Drug Delivery by Drug-Eluting Stents
    Bozsak, Franz
    Gonzalez-Rodriguez, David
    Sternberger, Zachary
    Belitz, Paul
    Bewley, Thomas
    Chomaz, Jean-Marc
    Barakat, Abdul I.
    PLOS ONE, 2015, 10 (06):
  • [13] Safety of drug-coated stents
    Biondi-Zoccai, Giuseppe G. L.
    Moretti, Claudio
    Lotrionte, Marzia
    Sheiban, Imad
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (05) : 597 - 606
  • [14] Drug coated stents for carotid intervention
    Tepe, G
    Schmehl, J
    Claussen, CD
    Ernemann, U
    Pereira, P
    Duda, SH
    JOURNAL OF CARDIOVASCULAR SURGERY, 2005, 46 (03): : 249 - 259
  • [15] Local drug delivery using coated stents: New developments and future perspectives
    Tanabe, K
    Regar, E
    Lee, CH
    Hoye, A
    van der Giessen, WJ
    Serruys, PW
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (04) : 357 - 367
  • [16] Absorbable polyester waxes for drug delivery.
    Nathan, A
    Borgia, M
    Twaddle, T
    Kataria, R
    Cui, H
    Peeters, J
    Verreck, G
    Monbaliu, J
    Fransen, J
    Borghys, H
    Brewster, M
    Arnold, S
    Rosenblatt, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U477 - U477
  • [17] Polymer-free drug-coated stents: workhorse or "niche horse"?
    Urban, Philip
    Chevalier, Bernard
    EUROINTERVENTION, 2018, 14 (07) : 732 - 735
  • [18] Sugar-coated polymer synthesis: From sustainable materials to selective drug delivery
    Reineke, Theresa M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [19] Tracking tissue distribution and retention of Sirolimus and analog delivered from polymer free drug coated stents
    Tzafriri, Abraham
    Daurella, Lucas Rotllant
    Keating, John
    Li, Xiaojian
    Gacia-Polite, Fernando
    Bailey, Lynn
    Markham, Peter
    Dutta, Debashis
    Stoll, Hans-Peter
    Edelman, Elazer
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B204 - B204
  • [20] Drug Delivery Nanosystems for Cardiovascular Stents
    Bakola, V.
    Karagkiozaki, V.
    Pappa, F.
    Tsiapla, A. R.
    Pavlidou, E.
    Moutsios, I.
    Laskarakis, A.
    Logothetidis, S.
    MATERIALS TODAY-PROCEEDINGS, 2017, 4 (07) : 6869 - 6879